ArticleFrontiers in pharmacology2025
Implementation of pharmacist recommendations following medication reviews in aged care.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Healthcare professionals' perspectives of pharmacist roles in residential aged care: a qualitative systematic review and meta-synthesis.International journal of clinical pharmacy · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Residential medication management reviews (RMMRs) are a government-funded program in Australia, designed to optimise medication use and enhance safety in aged care residents through reviews conducted by credentialed pharmacists. However, variability in general practitioners' (GPs) implementation of pharmacists' recommendations may limit their effectiveness. This study investigated the recommendations made by pharmacists during RMMRs, and the aspects of the recommendations that were associated with their subsequent implementation by GPs. Methods: This retrospective study analysed RMMRs from 54 aged care facilities across Tasmania, Australia between January 2020 and December 2023. Residents with at least two RMMRs spaced approximately 12 months apart were included, with data extracted from the earliest eligible RMMR as the index. Data sources included medication profiles, residents' clinical histories, RMMR reports, GP feedback forms, and follow-up RMMRs. Results: Of the 1646 index RMMRs analysed, 3774 recommendations were made (median: 2 per RMMR), with 50% (n = 1872) fully implemented by the next RMMR 12 months later. Most recommendations (91%, n = 3380) involved a change in therapy, primarily medicine cessation (49%, n = 1810) or dose reduction (21%, n = 799), with implementation rates of 51% and 49%, respectively. Common deprescribing targets included colecalciferol (n = 318, 37% implemented), proton pump inhibitors (n = 123, 43% implemented), statins (n = 145, 48% implemented), and low-dose aspirin (n = 107, 63% implemented). One in six recommendations involved a potentially inappropriate medicine (PIM) according to an Australian resource, such as antipsychotics, benzodiazepines, and opioids. Implementation rates were comparable between deprescribing of PIMs and non-PIMs (51% vs. 50%, p > 0.9). Monitoring-related recommendations were significantly more likely to be implemented than those involving a change in therapy (73% vs. 48%, p < 0.001). Conclusion: Half of all recommendations were implemented by GPs within 12 months, with most targeting the deprescribing of preventive or high-risk medicines. Future research should identify which recommendations GPs prioritise and the factors influencing their implementation of pharmacists' medication review recommendations, in order to enhance the effectiveness of RMMRs in aged care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.